期刊文献+

慢性心力衰竭性贫血的研究进展 被引量:3

下载PDF
导出
摘要 慢性心力衰竭(chronic heart failure,CHF)是人们日益关注的公共健康问题,是各种心脏疾患的终末阶段,其发病率呈逐年上升趋势。尽管近几十年来,CHF的药物和非药物治疗在改善患者临床症状和预后方面有了较大进展,但CHF的死亡率仍很高。
出处 《中国医学创新》 CAS 2011年第25期185-186,共2页 Medical Innovation of China
  • 相关文献

参考文献16

  • 1Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe ,resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitali- zations. J Am Coil Cardio1,2000,35 ( 7 ) : 1737 - 1744.
  • 2Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes : insights from a co- hort of 12065 patients with new onset heart failure. Circulation, 2003,107(2) :223 -225.
  • 3叶长青,郑兴.住院慢性心衰患者贫血患病率与心功能的关系及血红蛋白浓度对其住院死亡率的影响[J].第二军医大学学报,2006,27(9):977-980. 被引量:9
  • 4Anand IS, Kuskowski MA, Rector TS, et al. Anemia and change in he- moglobin over time related to mortality and morbidity in patients with chronic heart failure results from Val - Heft. Circulation,2005,112 (8) :1121 - 1127.
  • 5Androne AS, Katz SD, Lund L, et al. Hemodilution is common in pa- tients with advanced heart failure. Circulation, 2003, 107 (2): 226 - 229.
  • 6Silverberg DS, Wexler D, Iaina A. The importance of anemia and its correction in the management of severetive heart failure. Eur J Heart Fail ,2002,4 (6) :681 - 686.
  • 7Chatterjee B, Nydegger UE, Mohacsi P. Serum erythropoietin in heart failure patients treated with ACE inhibitors or ATI antagonists. Eur J Heart Fail,2000,2 (4) : 393 - 398.
  • 8Ishani A, Weinhandl E, Zhao Z, et al. Angiotensin - conveyting en- zyme inhibitor as a risk f actor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Gardiol,2005,45 (3) :391 - 399.
  • 9Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symtoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart fail- ure. J Am Coll,2002,39 ( 11 ) : 1780 - 1786.
  • 10Sharma R, Francis DP, Pitt B, et al. Haemoglobin predicts survival in patients with chronic heart failure :a sub study of the ELITE Ⅱ trial. Eur Heart J,2004,25 (12) :1021 - 1028.

二级参考文献17

  • 1Sharma R,Francis D,Pitt B,et al.Hemoglobin predicts survival in patients with chronic heart failure:a substudy of the ELITE Ⅱ trial[J].Eur Heart J,2004,25:1021-1028.
  • 2Ezekowitz JA,McAlister FA,Armstrong PW.Anemia is common in heart failure and is associated with poor outcomes:insights from a cohort of 12,065 patients with new-onset heart failure[J].Circulation,2003,107:223-225.
  • 3Al-Ahmad A,Rand WM,Manjunath G,et al.Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction[J].J Am Coll Cardiol,2001,38:955-962.
  • 4Felker GM,Gattis WA,Leimberger JD,et al.Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure[J].Am J Cardiol,2003,92:625-628.
  • 5Nordyke RJ,Kim JJ,Goldberg GA,et al.Impact of Anemia on hospitalization time,charges,and mortality in patients with heart failure[J].Value Health,2004,7:464-471.
  • 6Mehra MR,Uber PA,Francis GS.Heart failure therapy at a crossroad:are there limits to the neurohormonal model[J]? J Am Coll Cardiol,2003,41:1606-1610.
  • 7Horwich TB,Fonarow GC,Hamilton MA,et al.Anemia is associated with worse symptoms,greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure[J].J Am Coll Cardiol,2002,39:1780-1786.
  • 8Silverberg DS,Wexler D,Sheps D,et al.The effect of correction of mild anemia in severe,resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron:a randomized controlled study[J].J Am Coll Cardiol,2001,37:1775-1780.
  • 9Silverberg DS,Wexler D,Blum M,et al.The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe,resistant congestive heart failure improves cardiac and renal function and functional cardiac class,and markedly reduces hospitalizations[J].J Am Coll Cardiol,2000,35:1737-1744.
  • 10Pentimone F,Del Corso L,Frustaci G,et al.Clinical evaluation of anemia in the aged[J].Minerva Med,1992,83:35-39.

共引文献8

同被引文献44

  • 1高艳玲,林宏扬,葛志明.心力衰竭性贫血的研究进展[J].中国老年学杂志,2004,24(11):1088-1090. 被引量:12
  • 2马依彤,李霞,王朝霞.慢性心力衰竭患者中贫血的患病情况[J].临床心血管病杂志,2007,23(1):37-39. 被引量:6
  • 3郭玲,王爱红,吕琳,鹿克风,孙永乐.EPO辅助治疗慢性心力衰竭合并贫血52例临床观察[J].山东医药,2007,47(5):57-58. 被引量:10
  • 4郗爱旗,褚以德,钟欣,李英兰,廖宝霞,尚玲,李国峰,赵文蕊.慢性心力衰竭患者贫血与肾功能和神经内分泌细胞因子的关系[J].中华老年心脑血管病杂志,2008,10(1):24-26. 被引量:7
  • 5Nagaya N,Miyatake K,Uematsu M,et al.Hemodynamic,renal,and hormonal effects of ghrelin infusion in patients with chronic heart failure[J].J Clin Endocrinol Metab,2001,86(12):5854-5859.
  • 6Nagaya N,Kangawa K.Therapeutic potential of ghrelin in the treatment of heart failure[J].Drugs,2006,66(4):439-448.
  • 7Nagaya N,Kojima M,Uematsu M,et al.Hemodynamic and hormonal effects of human ghrelin in healthy volunteers[J].Am J Physiol Regul Integr Comp Physiol,2001,280(5):1483-1487.
  • 8Nagaya N,Kangawa K.Ghrelin,a novel growth hormonereleasing petide,in the treatment of chronic heart failure[J].Regul Pept,2003,114(2-3):71-77.
  • 9Nagaya N,Uematsu M,Kojima M,et al.Elevated circulating level of ghrelin in cachexia associated with chronic heart failure:relationships between ghrelin and anabolic/catabolic factors[J].Circulation,2001,104(17):2034-2038.
  • 10Xu J P,Wang H X,Wang W,et al.Ghrelin improves disturbed myocardial energy metabolism in rats with heart failure induced by isoproterenol[J].J Pept Sci,2010,16(8):392-402.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部